Author:
Midgard Håvard,Ulstein Kjersti,Backe Øystein,Foshaug Tarjei,Sørli Hanne,Vennesland Kristin,Nilssen David,Dahl Elin Hoffmann,Finbråten Ane-Kristine,Wüsthoff Linda,Dalgard Olav
Subject
Health Policy,Medicine (miscellaneous)
Reference27 articles.
1. Low hepatitis C reinfection following direct-acting antiviral therapy among people who inject drugs on opioid agonist therapy;Akiyama;Clinical Infectious Diseases,2020
2. Clinicians’ views of hepatitis C virus treatment candidacy with direct-acting antiviral regimens for people who inject drugs;Asher;Substance Use & Misuse,2016
3. Reinfection following successful direct-acting antiviral therapy for hepatitis C infection among people who inject drugs;Cunningham;Clinical Infectious Diseases,2020
4. Adherence to once-daily and twice-daily direct-acting antiviral therapy for hepatitis C infection among people with recent injection drug use or current opioid agonist therapy;Cunningham;Clinical Infectious Diseases,2020
5. Dalgard, O., Bjøro, K., Karlsen, L., Kielland, K.B., .Konopski, Z., Kristiansen, M.G. et al. (2019). Norwegian guidelines for assessment and treatment of hepatitis C infection 2019. https://www.legeforeningen.no/contentassets/a99bd0235fdf415fb7323daf908da32e/veileder-revisjon-8-.pdf.
Cited by
21 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献